COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 1820: Articles 18191-18200  | Next

Recent and forecast post-COVID trends in hospital activity in England amongst 0 to 24 year olds: analyses using routine hospital administrative data
Ward, J., Hargreaves, D., Rogers, M., Firth, A., Turner, S., Viner, R., On behalf of the Royal College of Paediatrics and Child Health Paediatrics 2040 Data Working Group
10.1101/2021.02.11.21251584 — Posted: 2021-02-15
SARS-CoV2 envelop proteins reshape the serological responses of COVID-19 patients
Martin, S., Heslan, C., Jegou, G., Eriksson, L. A., Le Gallo, M., Thibault, V., Chevet, E., Avril, T.
10.1101/2021.02.15.431237 — Posted: 2021-02-15
SARS CoV-2 nucleoprotein enhances the infectivity of lentiviral spike particles
Mishra, T., M, S., Ramdas, P., Sahu, A. K., Kumar, A., Chande, A.
10.1101/2021.02.11.430757 — Posted: 2021-02-15
Jumper Enables Discontinuous Transcript Assembly in Coronaviruses
Sashittal, P., Zhang, C., Peng, J., El-Kebir, M.
10.1101/2021.02.12.431026 — Posted: 2021-02-15
Pulsed broad-spectrum UV light effectively inactivates SARS-CoV-2 on multiple surfaces
Jureka, A. S., Williams, C. G., Basler, C. F.
10.1101/2021.02.12.431032 — Posted: 2021-02-15
Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin
Qian, Y., Lei, T., Patel, P., Lee, C., Monaghan-Nichols, P., Xin, H.-B., Qiu, J., Fu, M.
10.1101/2021.02.14.431174 — Posted: 2021-02-15
In vitro efficacy of Artemisia extracts against SARS-CoV-2
Nie, C., Trimpert, J., Moon, S., Haag, R., Gilmore, K., Kaufer, B. B., Seeberger, P. H.
10.1101/2021.02.14.431122 — Posted: 2021-02-15
HaVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences
Nguyen, P. T., Plyusnin, I., Sironen, T., Vapalahti, O., Kant, R., Smura, T.
10.1101/2021.02.12.431018 — Posted: 2021-02-15
SARS-CoV-2 lineage B.1.526 emerging in the New York region detected by software utility created to query the spike mutational landscape
West, A. P., Barnes, C. O., Yang, Z., Bjorkman, P. J.
10.1101/2021.02.14.431043 — Posted: 2021-02-15 Discussion: Onsite
SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of October 2020 to February 2021 – implementation of Swiss-wide diagnostic screening and whole genome sequencing
Ana Rita Goncalves Cabecinhas, Tim Roloff, Madlen Stange, Claire Bertelli, Michael Huber, Alban Ramette, Chaoran Chen, Sarah Nadeau, Yannick Gerth, Sabine Yerly, Onya Opota, Trestan Pillonel, Tobias Schuster, Cesar M.J.A. Metzger, Jonas Sieber, Michael Bel, Nadia Wohlwend, Christian Baumann, Michel C. Koch, Pascal Bittel, Karoline Leuzinger, Myrta Brunner, Franziska Suter-Riniker, Livia Berlinger, Kirstine K. Søgaard, Christiane Beckmann, Christoph Noppen, Maurice Redondo, Ingrid Steffen, Helena M.B. Seth-Smith, Alfredo Mari, Reto Lienhard, Martin Risch, Oliver Nolte, Isabella Eckerle, Gladys Martinetti Lucchini, Emma B. Hodcroft, Richard A. Neher, Tanja Stadler, Hans H. Hirsch, Stephen L. Leib, Lorenz Risch, Laurent Kaiser, Alexandra Trkola, Gilbert Greub, Adrian Egli
10.1101/2021.02.11.21251589 — Posted: 2021-02-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).